By TOM MARINER // In an era when many domestic pharmaceutical companies have moved manufacturing offshore, one of America’s largest generic drugmakers has taken a decidedly different path. Amneal Pharmaceuticals…
By TOM MARINER // In an era when many domestic pharmaceutical companies have moved manufacturing offshore, one of America’s largest generic drugmakers has taken a decidedly different path. Amneal Pharmaceuticals…
When last we spoke (he was a guest in December on Spark: The Innovate Long Island Podcast), Accelerate Long Island Program Director Dan Lloyd discussed Long Island’s potential as…
By JACI CLEMENT // One of the best illustrations of how disconnected organizations, communities and the news media have become is through the lens of time. Time means something different…
By TOM STEBBINS // New York’s reputation for excessive litigation and the state’s uniquely costly liability laws remain major obstacles to attracting the industries of the future, revitalizing the economy…
